The Effect of Dulaglutide (LY2189265) on the Pharmacokinetics and Pharmacodynamics of Single Dose Warfarin in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 29 Mar 2017
At a glance
- Drugs Dulaglutide (Primary) ; Warfarin
- Indications Thromboembolism; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 29 Mar 2017 Results of pooled analysis from four trials (NCT01458210, NCT01436201, NCT01432938, and NCT01250834) assessing the effect of dulaglutide on PK of digoxin, warfarin, atorvastatin and Ortho-Cyclen and PD of warfarin, published in the Clinical Pharmacokinetics
- 17 Jan 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov
- 19 Sep 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.